Inventor
COREY DON ANDERSON
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds22%
C07BGeneral methods of organic chemistry15%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
12,421,251Cystic fibrosis transmembrane conductance regulator modulating agents202512,319,693Crystalline forms of CFTR modulators202512,122,788Process of making CFTR modulators202411,873,300Crystalline forms of CFTR modulators202411,866,450Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators202411,591,350Modulators of cystic fibrosis transmembrane conductance regulator202311,584,761Process of making CFTR modulators2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to VERTEX PHARMA (7)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 7 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2023–2025 |